Kevin Smith
Vorstandsvorsitzender bei INOGEN, INC.
Vermögen: - $ am 30.04.2024
Profil
Kevin R.
Smith currently works at Inogen, Inc., as President, Chief Executive Officer & Director from 2023.
Mr. Smith also formerly worked at Sirtex Medical US Holdings Inc, as President, CEO & Executive Director from 2019 to 2023, OncoSec Medical, Inc., as Director from 2022 to 2023, Teleflex, Inc., as Global Vice President-Sales & Marketing, Medcura, Inc., as Executive Vice President-Business Development, and Sensium Healthcare Ltd., as Chief Commercial Officer.
Mr. Smith received his undergraduate degree from the University of Kentucky and Masters Business Admin degree from the University of Phoenix.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INOGEN, INC.
-.--% | 01.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
| 21.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Kevin Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| INOGEN, INC. | Vorstandsvorsitzender | 10.11.2023 |
Ehemalige bekannte Positionen von Kevin Smith
| Unternehmen | Position | Ende |
|---|---|---|
Sirtex Medical US Holdings Inc
 Sirtex Medical US Holdings Inc BiotechnologyHealth Technology Sirtex Medical US Holdings Inc is a private company that operates as a manufacturer of targeted liver cancer therapies. The company is based in Woburn. The CEO of the American company is Kevin R. Smith. | Vorstandsvorsitzender | 01.11.2023 |
| ONCOSEC MEDICAL INCORPORATED | Vorstandsvorsitzender | 02.05.2022 |
| TELEFLEX INCORPORATED | Vertrieb & Marketing | - |
Sensium Healthcare Ltd.
 Sensium Healthcare Ltd. Medical/Nursing ServicesHealth Services Sensium Healthcare Ltd. provides health care services. It offers vital signs monitoring, wireless medical devices, ultra-low power wireless technologies. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Medcura, Inc.
 Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Corporate Officer/Principal | - |
Ausbildung von Kevin Smith
| University of Kentucky | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TELEFLEX INCORPORATED | Health Technology |
| INOGEN, INC. | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Private Unternehmen | 3 |
|---|---|
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
Sensium Healthcare Ltd.
Sensium Healthcare Ltd. Medical/Nursing ServicesHealth Services Sensium Healthcare Ltd. provides health care services. It offers vital signs monitoring, wireless medical devices, ultra-low power wireless technologies. The company is headquartered in London, the United Kingdom. | Health Services |
Sirtex Medical US Holdings Inc
Sirtex Medical US Holdings Inc BiotechnologyHealth Technology Sirtex Medical US Holdings Inc is a private company that operates as a manufacturer of targeted liver cancer therapies. The company is based in Woburn. The CEO of the American company is Kevin R. Smith. | Health Technology |
